中信里昂維持貝康醫療(02170.HK)目標價44.2港元 維持買入評級 2021-06-01T02:09:16-04:00June 1st, 2021| share this article!【財華社訊】中信里昂維持貝康醫療(02170.HK)目標價44.2港元,維持買入評級。該公司股價今早開盤大幅下挫逾5%,盤中見最低價26.8港元。現報27港元,跌4.26%,成交量27萬,成交額738.41萬港元。 Read More share this article! Related Posts Buffett’s Berkshire Hathaway reduces large Apple stake May 4th, 2024 Can China’s sci-fi industry, led by 3 Body Problem, help tech hit warp speed? May 4th, 2024 Black rain dampens sales at Great Eagle’s Onmantin project in Ho Man Tin May 4th, 2024 Opinion | Suddenly, the US bull market isn’t looking so great May 4th, 2024